Key result
Percutaneous transluminal coronary angioplasty led to a significant loss of >50% of degranulated, activated platelets during the procedure, followed by a uniform increase post-procedure.
Why the study?
Does PTCA induce periprocedural changes in platelet activation in patients undergoing elective PTCA?
Observational (n=25)
Does PTCA induce periprocedural changes in platelet activation in patients undergoing elective PTCA?
PTCA induces consumption of preactivated platelets and sustained platelet activation post-procedure, which may contribute to periprocedural ischemic events.
Answers are grounded in this paper and cite their sources.
May link PTCA platelet consumption and rebound to ischemic risk; hypothesis-generating for periprocedural antiplatelet optimization.
BACKGROUND: Percutaneous transluminal coronary angioplasty (PTCA) with its various manipulations could create a dangerous, sudden haemostatic response. This study was performed to investigate PTCA-induced periprocedural changes in platelet activation and its consequences. METHODS: Twenty-five consecutive patients admitted for elective PTCA were preclassified as having or not having circulating activated platelets. Blood samples were taken for platelet activation marker analysis before, six times during and 2 h after PTCA. Intravascular platelet activation was analysed by flow cytometry to measure activation-dependent surface markers thrombospondin, P-selectin (CD62) and lysosomal GP53 (CD63). RESULTS: PTCA was associated with a significant reduction of peripheral platelet count. The initiation of the PTCA procedure led to a significant loss of more than 50% of the degranulated, activated platelets. After PTCA, the number of degranulated, activated platelets uniformly increased. CONCLUSIONS: We conclude that PTCA can induce consumption, particularly of preactivated platelets, and lead to sustained platelet activation after the procedure. This might explain why preactivated patients are at increased risk of suffering periprocedural ischaemic events and why increased thrombogenicity favours acute flow disruption and the progression of coronary stenosis at the lesion site.
No takes yet. Share an insight, caveat, or question.
Kolarov et al. (1996) conducted an observational in Elective PTCA (n=25). Percutaneous transluminal coronary angioplasty (PTCA) vs. Baseline (before PTCA) was evaluated on Periprocedural changes in platelet activation and peripheral platelet count. Percutaneous transluminal coronary angioplasty led to a significant loss of >50% of degranulated, activated platelets during the procedure, followed by a uniform increase post-procedure.
Synapse has enriched 10 related papers. Consider them for comparative context: